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Abstract 
A variety of natural or synthetic calcium phosphate (CaP) based scaffolds are currently produced for 
dental and orthopaedic applications. These scaffolds have been shown to stimulate bone formation 
due to their biocompatibility, osteoconductivity and osteoinductivity. The release of the Ca2+ ions from 
these scaffolds is of great interest in light of the aforementioned properties. It can depend on a number 
of biophysiochemical phenomena such as dissolution, diffusion and degradation, which in turn depend 
on specific scaffold characteristics such as composition and morphology. Achieving an optimal release 
profile can be challenging when relying on traditional experimental work alone. Mathematical 
modelling can complement experimentation. In this study, the in vitro dissolution behaviour of four 
CaP-based scaffold types was investigated experimentally. Subsequently, a mechanistic finite element 
method (FEM) model based on biophysiochemical phenomena and specific scaffold characteristics was 
developed to predict the experimentally observed behaviour. Before the model could be used for local 
Ca2+ ions release predictions, certain parameters such as dissolution constant (kdc) and degradation 
constant (ksc) for each type of scaffold were determined by calibrating the model to the in vitro 
dissolution data. The resulting model showed to yield release characteristics in satisfactory agreement 
with those observed experimentally. This suggests that the mathematical model can be used to 
investigate the local Ca2+ ions release from CaP-based scaffolds. 
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1. Introduction 
Calcium phosphate (CaP) materials are widely used for dental and orthopaedic applications in the 
regeneration of bone defects, because of their chemical similarity to native bone tissue and their ability 
to induce bone formation along with providing structural support (Lanao et al. 2011). The release of 
calcium (Ca2+) and phosphate (Pi) ions by dissolution is believed to affect the bone cell chemotaxis, 
proliferation and differentiation. It has been reported in various in vitro studies that calcium ion 
concentrations between 2-8mM have a profound impact on bone cell fate but optimum in vivo calcium 
concentrations are still unknown (Bianchi et al. 2014; Bléry et al. 2014; Carlier et al. 2011; Chai et al. 
2012a; Chai et al. 2012b; Chai et al. 2012c; Charles-Harris et al. 2008; Danoux et al. 2015; Hong et al. 
2014; Karadzic et al. 2015; Lobo et al. 2015; Mazón et al. 2015; Roberts et al. 2011; Shih et al. 2014). 
Once the CaP materials are implanted in vivo, they should induce bone formation but should eventually 
completely degrade and be absorbed by the body. Ideally, the degradation rate should be similar to 
the rate of bone formation (Wu and Ding 2005). 
 
There are three major types of CaP materials used for bone tissue engineering applications: 
Hydroxyapatite (HA, Ca10(PO4)6(OH)2), Beta-tricalcium phosphate (β-TCP, Ca3(PO4)2) and Biphasic 
calcium phosphate (BCP). HA can cause infections due to low degradation, whereas high degradation 
of β-TCP diminishes its structural function. Having a mixture of HA and β-TCP results in BCP, which is 
more degradable than HA whereas more stable than β-TCP. As a result, the bioreactivity of BCPs can 
be controlled by manipulating the HA/β-TCP ratio (Hong et al. 2014). In addition to the chemical 
composition (HA/β-TCP ratio), varying surface-structural properties such as macro- and micro-
porosity, specific surface area, roughness and overall geometry, also affect bone formation (Bohner 
and Baumgart 2004; Danoux et al. 2015; Lobo et al. 2015; Mazón et al. 2015). Moreover, it has been 
reported that the porosity or the pore size can influence the degradation rate. Scaffolds with high 
porosity or small pore size degrade more slowly than those with low porosity or large pore size (Wu 
and Ding 2005). Given their widespread medical use, there remains a strong demand to design and 
develop CaP-based bone substitutes that have optimal chemical composition and surface-structural 
properties for the desired bone formation (Bohner and Baumgart 2004). However, experimentally 
determining the ideal combinations of chemical composition along with surface-structural properties 
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to maximize in vivo bone formation for specific applications can be challenging. Nevertheless, testing 
these different combinations in silico can save research time and costs.   
 
Accurate mathematical models can be used to facilitate the development of optimized degradable 
bone substitutes and other biomaterials by allowing rapid evaluation and validation of experimental 
parameters and also minimizing the number of required experimental studies (Frenning 2004; 
Kaunisto et al. 2013; Lao et al. 2011; Masaro and Zhu 1999; Siepmann et al. 1999; Siepmann and 
Siepmann 2013). In addition, they also allow quantitative understanding of the physical, chemical and 
biological phenomena involved in the controlled release of ions or molecules (Siepmann and Göpferich 
2001; Snorradóttir et al. 2013). Due to significant advances in information technology, mathematical 
modelling of biomaterial behaviour is increasing its academic and industrial importance, which makes 
it an integral part of future research and development in bone tissue engineering.  Concerning the 
development of optimized degradable scaffolds, the importance of such models lies in their relevance 
during the designing stage as well as the experimental verification of degradation and release 
mechanism. However, it is unlikely that there will be one mathematical model that will be able to 
describe any type of release of ions or molecules from biomaterials. It is much more likely that there 
will be different mathematical models, applicable to specific types of systems that differ in geometry 
and composition (Arifin et al. 2006; Brazel and Peppas 2000; Dash et al. 2010; Fredenberg et al. 2011; 
Frenning 2003; Frenning et al. 2005; Frenning and Strømme 2003; Frenning et al. 2003; Polakovič et al. 
1999; Siepmann and Peppas 2011; Siepmann and Siepmann 2008). Over the past few years, a few 
lattice based three-dimensional (3D) mathematical models have been proposed to study the in vivo 
bone formation process in porous biodegradable CaP scaffolds (Adachi et al. 2006; Byrne et al. 2007; 
Sun et al. 2013). Adachi et al. (2006) proposed a mathematical model of in vivo bone tissue 
regeneration that consisted of scaffold degradation due to hydrolysis. Byrne et al. (2007) proposed a 
mathematical model of in vivo tissue differentiation and bone regeneration in a degrading scaffold as 
a function of porosity, Young’s modulus, and dissolution rate. Sun et al. (2013) proposed a multiscale 
model of a biodegradable porous calcium phosphate (CaP) scaffold to examine the effects of pore size 
and porosity on bone formation and angiogenesis. However, the above mentioned models being 
lattice-based did not capture the actual geometry of the CaP scaffolds. Additionally, the models had 
phenomenological description of the degradation process as they were not interested in the 
degradation products themselves but rather in the changing stiffness and porosity of the scaffold.  
 
As the in vivo calcium release cannot be measured accurately, our first objective was to investigate the 
in vitro dissolution behaviour of CaP based scaffolds and develop a computational model that can 
replace the dissolution tests in the future. Certainly, our next objective will be to implement the model 
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to predict the in vivo bone formation process. To the best of our knowledge, we did not find any 
previous computational studies describing the in vitro dissolution and degradation of CaP-based 
scaffolds over time using accurate geometries. Therefore, in this paper we follow a combined 
experimental-modelling approach to be able to accurately describe the in vitro dissolution and 
degradation of CaP-based scaffolds over time, as schematically described in Figure 1. The in vitro 
dissolution behaviour of four CaP-based scaffold types (Bio-Oss®, Integra-Mozaik™, MBCP™ and 
ReproBone™) was investigated in phosphate-buffered saline (PBS). For mathematical simulations, we 
developed a mechanistic finite element method (FEM) model based on the Noyes-Whitney equation, 
the Fick’s second law of diffusion equation and the level-set method (LSM). The model was dependent 
on biophysicochemical phenomena such as dissolution, diffusion and degradation along with specific 
scaffold characteristics such as composition, size and shape. The microCT data provided input for the 
geometrical domain of the model. The values for model parameters such as the dissolution constant 
(kdc) and the degradation constant (ksc) were estimated from the Ca2+ ions release data measured from 
dedicated dissolution experiments. Additionally, convergence and sensitivity analyses were carried out 
to investigate in more detail certain model parameters relevant to Ca2+ ions release. A Partial Least 
Square Regressions (PLSR) analysis was used to identify linear relationships between scaffold 
characteristics and the kdc and ksc values which were used to estimate kdc* and ksc* values. The model 
outputs for both the sets of parameters were then compared. Finally, the linear relationships derived 
using PLSR were used to investigate in silico the dissolution behaviour of CaP biomaterials composed 
of different combinations of HA and β-TCP.  
 
2. Materials and Methods 
 
2.1 Calcium phosphate scaffolds 
Four types of commercially available and clinically used CaP or CaP/collagen composite bone void fillers 
were used as scaffolds in this study (Table 1). Both Bio-Oss® (Geistlich, Wolhusen, Switzerland) and 
Integra-MozaikTM (Integra LifeSciences, Plainsboro, USA) consist of CaP, which is distributed in an open 
collagen network, whereas MBCPTM (Biomatlante, Vigneux de Bretagne, France) and ReproBoneTM 
(Ceramisys Ltd., Sheffield, UK) only consist of CaP. CaP of Bio-Oss® consists of natural bone mineral 
made of bovine bone, whereas CaP of Integra-MozaikTM, MBCPTM and ReproBoneTM is of synthetic 
origin. Integra-MozaikTM is composed of 100% β-tricalcium phosphate (β-TCP), while MBCPTM and 
ReproBoneTM are composed of 60% hydroxyapatite (HA) and 40% β-TCP. All materials are described by 
the manufacturer as porous and in vivo resorbable. For this study, all the material blocks were cut with 
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a scalpel in cubes with a volume of 27mm3. All scaffolds were stored at room temperature and used 
under sterile conditions for all experiments.  
 
Table 1: Four commercially available scaffolds used in this study with their structural and material 
characteristics as provided by the manufacturers. No detailed data was provided for Integra-MozaikTM 
by the manufacturer 
Scaffold CaP composition Polymeric matrix 
type 
Macro pore size 
(µm) 
Micro pore 
size (µm) 
Total 
porosity (%) 
Bio-Oss® Bovine bone granules Col-I 200-600 0.1-1 83 
Integra-MozaikTM 100% β-TCP Col-I - - - 
MBCPTM 60% HA+40% β-TCP No polymeric matrix 300-600 <10 70 
ReproBoneTM 60% HA+40% β-TCP No polymeric matrix 200-800 1-10 80 
 
2.2 Structural characterization of the scaffolds using microfocus computed tomography  
The morphology and fractional composition (CaP/collagen/pores) of the scaffolds were characterized 
prior to (n=5) and after (n=1) the dissolution tests using microCT on a Phoenix NanoTom S (GE 
Measurements and Control Solutions, Germany) at an isotropic voxel size of 3µm3 (Table 2). The 
samples were scanned using a source voltage of 60kV and current of 162µA, and an aluminium filter 
of 0.3mm was used to reduce beam hardening. The obtained 2400 radiographic images were 
reconstructed with Phoenix datos|x CT software and the images were analyzed using the in-house 
developed software tool Morphing CiTy (ULg, Liege, Belgium) and the commercially available tool CTAn 
(Bruker Micro-CT Kontich, Belgium). Thresholding of the grey scale histogram using a multilevel Otsu 
algorithm allowed the quantification of structural parameters for the complete scaffold and also for 
CaP and collagen separately (Sonnaert et al. 2015). The dry weight normalized to the initial total 
scaffold volume (TSV) of each scaffold was recorded prior to (n=5) and after (n=1) the dissolution test 
(Table 2).  
 
Table 2: Overview of the experimental design used in this study. The microCT data available for 1 
scaffold at day 21 time point (after the dissolution test) was only used as a qualitative compliment to 
the study 
 Day (n) 
Bio-Oss® Integra-MozaikTM MBCPTM Repro BoneTM 
microCT analysis D 0 5 5 5 5 
D 21 1 1 1 1 
 
Dissolution 
experiments 
D 0 3 3 3 3 
D 1 3 3 3 3 
D 3 3 3 3 3 
D 6 3 3 3 3 
D 21 3 3 3 3 
Normalized Weight 
measurements 
D 0 5 5 5 5 
D 21 1 1 1 1 
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2.3 Calcium (Ca2+) dissolution kinetics of the scaffolds 
The dissolution kinetics of the scaffolds (n=3, see Table 2) in phosphate-buffered saline (PBS) solution 
(Biowhittaker®, without Ca2+ and Mg2+ ions) at 37°C were investigated  by placing scaffolds inside a 
15ml Eppendorf tube placed on an orbital rotator rotating at 10rpm. The PBS solution was refreshed 
at day 1, 3, 6 and 21. All the samples were stored at 4°C. Before measurement, 240µl nitric acid was 
added to the samples to ensure there was no precipitation in the medium (Roberts et al. 2011). The 
released Ca2+ over 21 days was measured by a calcium micro ion electrode (Lazar Research 
Laboratories, Inc., USA).  
 
2.4 Statistics 
Data are expressed as mean ± standard deviation (St. Dev.). Statistical significance was determined 
using the 1-way ANOVA with a posthoc Tukey test and the student t test. Statistical significance is 
indicated on all graphs as follows: *: p < 0.05, **: p < 0.01, ***: p < 0.001. Partial least square regression 
(PLSR) analysis was performed in JMP® 11 (SAS Institute Inc., Cary, NC).  
 
3. Mathematical Model 
 
3.1 Model formulation  
In this paper, we developed a mathematical model to predict the in vitro dissolution behaviour of CaP-
based scaffolds in PBS solution using the experimental dissolution results from Bio-Oss®, Integra-
MozaikTM, MBCPTM and ReproBoneTM. As the initial solid calcium concentration was larger than the 
solubility of the Ca2+ ions in PBS solution, the solid and the dissolved Ca2+ coexisted at the same time 
during the dissolution process. The concentration change of dissolved Ca2+ ions with time was 
described using a diffusion-dissolution equation (1). The Ca2+ ions diffusion process was implemented 
using Fick’s second law of diffusion whereas the dissolution process was implemented based on the 
Noyes-Whitney equation (Frenning et al. 2005) where the rate of dissolution of a substance is 
described as a function of, amongst others, the concentration of the substance and its diffusion 
coefficient.  
 
𝜕𝐶
𝜕𝑡
= 𝛻 ∙ (𝐷𝛻𝐶) + 𝑘𝑑𝑐
𝑆 𝐷
𝑉𝑃𝐵𝑆 
(𝐶𝑠𝑜𝑙 − 𝐶)                                                                                             (1) 
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where C is the dissolved Ca2+ ions concentration (mM), D is the diffusion coefficient (m2/s), kdc is the 
dissolution constant (m-1), S is the CaP surface area (m2) calculated from the input microCT image 
(Table 3), VPBS is the PBS volume (1.5 x 10-5 m3) and Csol is the solubility of the Ca2+ ions in PBS (mM). As 
the thickness of the boundary layer could not be measured experimentally, it was considered as a 
mathematical parameter that was incorporated in the kdc in equation (1). The diffusion coefficient of 
Ca2+ ions in PBS solution at 37°C was considered to be constant and it was calculated using Stokes-
Einstein equation (2) (Young et al. 1980) given below: 
 
𝐷 =
𝑘𝐵𝑇 
6𝜋𝜂𝑟
 = 2.83x10-9 m2/s                                                                                                                                  (2) 
 
where kB is the Boltzmann’s constant (1.38x10-23 m2 kg s-2 K-1), T is the absolute temperature (37°C 
=310.5 K) , 𝜂 is the viscosity of PBS at 37°C (0.0007 Pa s)  (Horbett et al. 1988) and r is the radius of Ca2+ 
ion (114 pm) (Shannon 1976). The diffusion coefficient (D) for calcium chloride (CaCl2) in aqueous 
solutions at 310.15 K has been reported to be (1.601 ± 0.02) x 10-9 m2/s (Ribeiro et al. 2008) which is 
of the same order of magnitude that was calculated theoretically in this study.   
 
To implement degradation of the scaffold, we used the level-set method (LSM) to track implicitly the 
movement of the scaffold interface Γ with velocity v during the dissolution process. To implement the 
LSM, a microCT cross-sectional image of a scaffold was projected on a 2D finite element domain Ω ⊂ 
ℝ2. The domain was then decomposed into two sub-domains Ω1 and Ω2, and the interface/boundary 
between two partitions was denoted by Γ. The level-set function (φ), a continuous scalar distance 
function, was then computed over the domain; φ was positive in Ω1 (scaffold), negative in Ω2 (PBS 
solution) and zero on Γ (boundary of the scaffold) (Figure 2). The motion of the interface (Γ) in the 
normal direction was described by the level-set equation (3) with a velocity field v (Guyot et al. 2014): 
 
𝜕𝜑
𝜕𝑡
= 𝑣|𝛻𝜑|                                                                                                                                                            (3) 
 
The degradation velocity v was derived by dividing the dissolution term in equation (1) by S∙Csol /VPBS, 
where S is the CaP surface area (m2), Csol is the solubility of Ca2+ ions in PBS (mM) and VPBS is the PBS 
volume (m3); thus, resulting in degradation velocity as shown below in equation (4), with ksc being a 
dimensionless degradation constant. 
 
𝑣 = 𝑘𝑠𝑐𝑘𝑑𝑐𝐷(𝐶𝑠𝑜𝑙 − 𝐶) /𝐶𝑠𝑜𝑙                                       (4) 
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In this model, the solubility (Csol) of Ca2+ ions was estimated to be 0.17 mM. The modelling of 
precipitation was not considered in this model as we did not detect precipitate formation during the 
experiments. The model also did not consider explicitly the influence of the CaP crystallinity or crystal 
size on the dissolution behaviour. The influence of collagen distribution around CaP in Bio-Oss® and 
Integra-MozaikTM on the Ca2+ ion dissolution was not modelled. 
 
3.2 Model implementation 
 
The mathematical domain for dissolution test simulation was represented by the front view of a 15ml 
Eppendorf tube (Figure 2). The model was implemented using the finite element method (FEM) with 
an open source partial differential equation (PDE) solver FreeFem++ (http://freefem.org) (Hecht 2012). 
This solver is well adapted for the type of model developed in this study due to its ability to deal with 
complex geometries and meshes, and its simplified way to treat any type of PDE by implementing its 
variational form. 
 
To implement the Dirichlet-type boundary condition for Ca2+ ions on a penalized FEM domain, we used 
an indicator function (𝑰𝛺1) which is described by equation (5), where φ is the level-set function. 
 
𝑰Ω1 := {
1 𝑖𝑓 𝒙 ∈  𝛺1 (𝜑 > 0)
0 𝑖𝑓 𝒙 ∉  𝛺1 (𝜑 ≤ 0)
                                       (5)  
 
The initial condition for dissolved Ca2+ ions was set as: 
 
C (0, Ω) = 0 for dissolved Ca2+ ions                         (6) 
 
To impose no-flux boundary condition, we implemented the homogenous Neumann boundary 
condition on ∂Ω as shown below: 
 
𝜕𝐶
𝜕𝑛
= 0                                                                                                               (7) 
 
Essentially, a convergence study (Online resource 1) was executed to determine a time step as well as 
a mesh-size independent numerical solution. This resulted in a time step of 3600 seconds and a number 
of elements being 115460. 
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3.3 Parameter estimation 
The model parameters used in this study were in part determined from physical laws, others were 
determined from the microCT data and yet some were estimated from the dissolution data. The 
diffusion coefficient (D) of Ca2+ ions in PBS solution at 37°C was calculated using the Stokes-Einstein 
equation (Young et al. 1980). The surface area (S) of only CaP was calculated from the microCT image. 
The PBS volume (VPBS) was determined from the dissolution experiments whereas the solubility (Csol) 
of the Ca2+ ions in PBS was estimated. For the dissolution constant (kdc), first the order of magnitude 
was theoretically calculated using equation (1) with only the dissolution term. The experimentally 
measured value of Ca2+ ion dissolution for each scaffold at day 1 was used to determine theoretically 
the order of magnitude of kdc. The model was then calibrated with the experimental release data of 
Ca2+ ions for each scaffold at day 1 to obtain the best fit. The kdc was estimated to be higher for Bio-
Oss® and Integra-Mozaik™. It was the highest for Bio-Oss® which was 2.7, 60.6 and 18.7 times higher 
than Integra-Mozaik™, MBCP™ and ReproBone™ respectively (Table 3). The effect of the boundary 
layer was considered as a mathematical parameter that was incorporated in the parameter kdc. The 
degradation constant (ksc) was estimated from the CaP volume and weight data from before and after 
the dissolution experiments (Online resource 2). It was estimated to be different between the fast 
degrading CaP types (Bio-Oss® and Integra-Mozaik™) and the slow degrading CaP type (MBCP™ and 
ReproBone™) (Table 3). Finally, the values for the sum of the squared residuals indicating the fit 
between the measured and the predicted Ca2+ ions release for each scaffold type are  shown in Table 
3. 
 
Table 3: Model parameter values used for the scaffolds. kdc and ksc are the estimated values whereas 
kdc* and ksc* are the values derived using PLSR by linking the structural and material properties. S 
represents the scaffold CaP surface area. Sum of squared residuals (kdc) depicts the fit between the 
measured and the predicted (with kdc and ksc) Ca2+ ions release. Sum of squared residuals (kdc*) depicts 
the fit between the measured and the predicted (with kdc* and ksc*) Ca2+ ions release 
 
Scaffold 
 
 
kdc 
(m-1) 
 
ksc 
Sum of 
squared 
residuals  
(kdc) 
 
Initial S 
(m2) 
 
kdc* 
(m-1) 
 
 
ksc* 
Sum of 
squared 
residuals 
(kdc*) 
Bio-Oss® 5x107  6.8x10-11 0.0029 3.29x10-6 5x107  7x10-11 0.0029 
Integra-MozaikTM 1.88x107 6.8x10-11 0.0129 2.89x10-6 1.88x107 7x10-11 0.0129 
MBCPTM 8.25x105  6.8x10-14 0.0058 5.96x10-6 1.75x106  8x10-14 0.0112 
ReproBoneTM 2.68x106  6.8x10-14 0.0088 2.98x10-6 1.75x106  8x10-14 0.0110 
 
 
3.4 Model outlook 
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With the aim of developing an accurate and credible model that allows predicting in vitro dissolution 
behaviour for CaP scaffolds outside of the training set without the need for additional experiments, a 
relationship was sought between the kdc and ksc values derived in this study and the structural and 
compositional characteristics of the scaffold materials. PLSR analysis allowed us to identify linear 
relationships between scaffold characteristics and the kdc and ksc values. To evaluate these 
relationships, they were used to estimate kdc* and ksc* values for all the scaffolds in the training set 
(Table 3) and the model outputs for both sets of parameters were then compared. The derived linear 
relationships were also used to estimate the kdc* and ksc* values for new CaP biomaterials with 
geometry as that of MBCP but with different combinations of HA and β-TCP (Table 4), which were then 
used to predict in silico the resulting dissolution behaviour. This allowed us to study in silico optimal 
biomaterial characteristics in order to obtain specific Ca release profiles.  
 
Table 4: PLSR derived model parameter values (kdc* and ksc*) for combination of different material 
composition of HA and β-TCP. B1-B4 represent different biomaterials of BCP type. S represents the 
scaffold CaP surface area 
 
CaP 
Biomaterial  
 
 
CaP Composition 
 
kdc* 
(m-1) 
 
ksc* 
 
Initial S 
(m2) 
MBCP 60% HA+40% β-TCP 1.75x106 8x10-14 5.96x10-6 
B1 50% HA+50% β-TCP 4.58x106  1x10-11 5.96x10-6 
B2 40% HA+60% β-TCP 7.42x106   2x10-11 5.96x10-6 
B3 20% HA+80% β-TCP 1.31x107  5x10-11 5.96x10-6 
B4 100% β-TCP 1.88x107  7x10-11 5.96x10-6 
 
 
4. Results  
4.1 Structural characteristics of the scaffolds 
 
To qualitatively and quantitatively investigate the structural characteristics of the scaffolds (n=5, see 
Table 2), microCT imaging was used. The reconstructed gray scale two-dimensional (2D) images (Figure 
3) show that Bio-Oss®, MBCP™ and ReproBone™ were more homogenous in morphology throughout 
the scaffold than Integra-Mozaik™. We also observed that Integra-Mozaik™ had a distribution of 
collagen and CaP  that was not consistent for the complete set of sections as it had collagen or CaP  
rich and poor zones, whereas the collagen in Bio-Oss® was more evenly distributed around CaP which 
was more homogenously distributed in the complete scaffold space. Both MBCP™ and ReproBone™ 
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had a similar CaP matrix structure, with ReproBone™ having more circular shaped pores and MBCP™ 
having on average a thicker CaP skeleton. The surface of Bio-Oss® was irregular, with collagen and CaP 
fully mixed together (Figure 3).  
 
The material characteristics of the scaffolds that were investigated before and after the dissolution 
tests using microCT were the CaP volume, collagen volume, total scaffold volume (TSV), total material 
volume (TMV), CaP specific surface area (SSA=CaP surface area/CaP volume) and CaP thickness. The 
TMV for collagen containing scaffolds (Bio-Oss® and Integra-Mozaik™) is the sum of CaP volume and 
collagen volume, whereas the TMV for the pure CaP scaffolds (MBCP™ and ReproBone™) is equal to 
the CaP volume. Due to inconsistent cutting, the TSV of the scaffolds showed variability, which is why 
all data was normalized to the initial TSV (leading to volume fractions, see Online Resource 2). There 
were significant differences in the initial CaP volume  fractions (Online Resource 2(a)) and the initial 
TMV fractions (Online Resource 2(b)) between Bio-Oss®, Integra-Mozaik™, MBCP™ and ReproBone™ 
(p < 0.01) . There was also a significant difference (p < 0.001) in the initial collagen volume fraction 
between Bio-Oss® and Integra-Mozaik™. The initial collagen volume fraction was higher for Integra-
Mozaik™ (Online Resource 2(c)). There were also significant differences in the initial weight fractions 
between Bio-Oss®, Integra-Mozaik™, MBCP™ and ReproBone™ (p < 0.01) (Online Resource 2(d)). 
 
4.2 Experimental dissolution behaviour of the scaffolds 
 
To measure released Ca2+ ions from each biomaterial, scaffolds (n=3) were incubated in PBS over a 
period of 21 days. The medium was changed periodically at various time points (day 1, 3, 6 and 21). In 
Figure 4, the plots show the cumulative Ca2+ ion release measured over period of time. The scatter 
plots show the experimentally measured values, the solid lines show the Ca2+ ion release predicted by 
initially estimated kdc and ksc values and the dashed lines show the Ca2+ ion release predicted by PLSR 
derived kdc* and ksc* values. The values shown for scatter plots are the averages of 3 repeated 
measurements from 3 different scaffolds, while the error bars indicate ± SD. 
 
In the experiments, the Ca2+ release was measured to be higher for Bio-Oss® and Integra-Mozaik™ in 
comparison to ReproBone™ and MBCP™. Bio-Oss® had the highest overall Ca2+ release (Figure 4(a)), 
whereas MBCP™ and ReproBone™ had the lowest and very similar release profiles (Figure 4 (c and d)).  
The overall cumulative Ca2+ release for Bio-Oss® was measured to be approximately 1.45, 1.68 and 1.77 
times higher than Integra-Mozaik™, MBCP™ and ReproBone™, respectively (Figure 4). No significant 
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differences in day 21 release were observed when comparing MBCP™ with Integra-Mozaik™ and 
ReproBone™ (p > 0.05).   
  
4.3 Mathematical dissolution behaviour of the scaffolds 
Once the model parameters such as kdc and ksc were estimated by calibrating the model to the 
experimental results, the model was allowed to run up to 21 days to predict the experimental 
dissolution behaviour. The solid lines in Figure 4 depict the predicted amount of Ca2+ ions released over 
the experimental measurement time. The values for the sum of the squared residuals indicating the fit 
between the measured and the predicted Ca2+ ions release (using kdc and ksc ) for each scaffold type 
are  shown in Table 3. It is evident that there is an agreement between the predicted (solid lines) and 
the experimentally measured (scatter plots) cumulative release (Figure 4). The model was also able to 
predict the spatio-temporal degradation and the dissolution of scaffolds over time. Figure 5 (a-c) 
depicts the degradation of Bio-Oss® predicted on day 0, day 10 and day 21 whereas Figure 5 (d-f) depicts 
the local concentration of Ca2+ ions predicted during  dissolution at the same time points.  
 
Afterwards, the estimated kdc and ksc were linked to the structural and material properties obtained 
from the microCT analysis, using PLSR (Table 3). From equations (1), (8) and (9), it can be inferred that 
the dissolution and degradation of CaP in scaffolds are primarily governed by scaffold composition (% 
bovine bone granules, % β-TCP, % HA). Structural parameters such as the CaP surface area and porosity 
are taken into account through the input microCT image.  
 
𝑘𝑑𝑐*= 10
5 (- 95.83 + 5.95 * % Bovine bone + 2.83 * % β-TCP)                                                                     (8)                     
 
𝑘𝑠𝑐*= 10
-11 (6.8- 0.1132 * % HA)                                                                                                                        (9)       
 
With the initially estimated kdc and ksc values, the model predicted CaP degradation between 9-18% 
for Bio-Oss® and Integra-Mozaik™ whereas the predicted CaP degradation was between 0.5-5% for 
MBCP™ and ReproBone™ (Figure 6(a)). The microCT CaP volume change data normalized to the initial 
total scaffold volume (TSV) qualitatively confirmed the degradation prediction by the model (Figure 
6(b)). 
 
4.4         Model sensitivity analysis and outlook 
We carried out the single-parameter sensitivity analysis to investigate the effect of a number of 
estimated parameters on the simulation outcome, which is shown in Figure 7. We investigated the 
13 
 
effect of altering the value for solubility (Csol) and observed that it altered the final outcome. A ten 
percent change in this value resulted in a corresponding ten percent change in the predicted calcium 
release (Figure 7(a)). Additionally, we investigated the influence of using other representative 2D 
images of Bio-Oss® and Integra-Mozaik™ in the model domain. We observed no significant differences 
in simulation results when using other images from the same stack for the Bio-Oss® scaffold (Figure 
7(b)), however we did find larger differences for Integra-Mozaik™ which has a more heterogeneous 
structure (Figure 7(c)). 
 
Additionally, the obtained relationships between the kdc and ksc and the compositional characteristics 
were tested by using the kdc* and the ksc* values calculated from equation (8) and (9) for each scaffold 
type to predict the experimental dissolution behaviour. Figure 4 shows a satisfactory agreement 
between the predicted (solid lines), PLSR derived (dashed lines) and experimentally measured (scatter 
plots) release of Ca2+ ions, which demonstrates acceptable accuracy of the model's representation of 
the real in vitro dissolution experimental setup. The values for the sum of the squared residuals 
indicating the fit between the measured and the predicted Ca2+ ions release (using kdc* and ksc* ) for 
each scaffold type are  shown in Table 3. In addition, for scaffold degradation, the PLSR derived kdc* 
and ksc* values were similar to the initially estimated values, as was the model outcome obtained with 
those PLSR derived values (Figure 6). Finally, using the PLSR derived linear relationships, the model was 
used to investigate the dissolution behaviour of a biomaterial with geometry as that of MBCP but with 
different combinations of HA and β-TCP (Figure 8). It is clearly evident that the increase of β-TCP in 
biomaterial composition resulted in higher dissolution (Figure 8(a)) along with higher degradation 
(Figure 8(b)) whereas the effect of HA in biomaterial composition was completely opposite to β-TCP.  
 
5. Discussion  
In this study, a combined experimental-modelling approach was used to describe the in vitro 
dissolution of CaP-based scaffolds over time. First, the in vitro dissolution kinetics of chemically and 
structurally different CaP biomaterials were investigated in PBS. Proceeding from the in vitro 
experiments, a 2D FEM model based on the diffusion-dissolution equation along with the level-set 
equation was developed to predict the in vitro dissolution behaviour of CaP-based scaffolds in PBS 
solution. The model parameters were either determined from the experimental results or derived from 
the results described in the literature or estimated. The model was able to capture the in vitro 
dissolution of Ca2+ ions in accordance with the experimental reports. Additionally, a single-parameter 
sensitivity analysis was carried out to determine the influence of specific model parameters on the 
predicted outcome. This obtained model is able to predict the dissolution behaviour of CaP-based 
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scaffolds as well as the local calcium concentration inside the scaffold based on the parameters that 
can be obtained from microCT imaging. In order to limit the amount of experimental work needed to 
make predictions for scaffold materials within the training set, relations were derived between the 
scaffold compositional characteristics and the kdc and ksc values and then tested on the training set 
itself. Finally, using the PLSR derived linear relationships, the model was used to investigate the 
dissolution behaviour of a biomaterial with different combinations of HA and β-TCP. 
 
In this study, the in vitro dissolution kinetics of biomaterials broadly classified as fast degrading (Bio-
Oss® and Integra-Mozaik™) and slow degrading (MBCP™ and ReproBone™) scaffolds were investigated 
in PBS. The four biomaterials contained different chemical formation and volume percentages of CaP, 
along with different structural characteristics such as collagen volume, total scaffold volume (TSV) and 
total material volume (TMV). The observed chemical and structural variations between scaffold types 
allowed for differences in release kinetics of Ca2+ ions in PBS medium, where the fast degrading 
scaffolds were found to have higher in vitro dissolution than the slow degrading scaffolds (Figure 4). It 
is worth mentioning that the dissolution of bovine bone granules in Bio-Oss® is higher when compared 
to synthetic HA (Mezahi et al. 2009). We did not detect precipitate formation. 
 
The reported mathematical analysis of in vitro dissolution behaviour of CaP-based biomaterials is the 
most mechanistic model published to date. Previous models describing CaP-based scaffold dissolution 
behaviour were either theoretical in nature (Bohner and Baumgart 2004) or lattice-based that did not 
capture the actual geometry of the CaP scaffolds. Additionally, the lattice based models used a 
phenomenological description of the degradation process (Adachi et al. 2006; Byrne et al. 2007; Sun 
et al. 2013). However, by explicitly incorporating dedicated experimental results along with taking into 
account the accurate geometrical shape of the scaffolds, this study takes an important step towards 
the use of in silico modelling in biomaterial design. This study focuses on measurements and modelling 
of Ca2+ ions dissolution, so it did not consider the influence of the micro-porosity, collagen distribution, 
CaP crystallinity or crystal size, precipitation, phosphate (PO43-) ions dissolution or changing collagen 
volume on the diffusivity behaviour of Ca2+ ions. Ultimately, these influences will need to be included 
comprehensively in the model (Gao and Fagerness 1995). Additional simplifications made in the course 
of this study pertain mainly to the modelling aspects. The first simplification to be dealt with in the 
future is the fact that the model only looks at dissolution kinetics in 2D, thereby neglecting any 3D 
spatial aspects, which might influence the overall numerical solution. It has been reported that the 
parameter values estimated by the 2D model could be overestimated with respect to the ones 
predicted by the 3D model, which could influence the overall output of the model (Nava et al. 2013). 
The second simplification included in the model was exclusion of solving the fluid flow due to rotation 
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during the dissolution experiment as well as the advection of Ca2+ ions due to fluid flow and the 
movement of scaffold due to rotation. This was done to keep the model computationally inexpensive 
and is in line with other models studying drug release from carriers under dynamic conditions (Arifin 
et al. 2006; Frenning et al. 2003; Snorradóttir et al. 2013). It is worth stating that this model can be 
adapted to potentially recapitulate the local in vivo (where the fluid flow is not so important) Ca2+ ion 
concentrations during the dissolution process by making adjustments to the existing parameters and 
including additional parameters specific to the in vivo environment.  
 
The values for unknown parameters such as dissolution constant (kdc) and degradation constant (ksc) 
for each scaffold type were determined by calibrating the model to the experimental release data of 
Ca2+ ions. It is evident from Figure 4 that there was overall an acceptable though not perfect agreement 
between the predicted (solid lines) and the experimentally measured (scatter plots) release profiles. It 
is also evident from Figure 4 that the model is not able to accurately capture the initial release. This 
could be due to the fact that the model does not consider advection of Ca2+ ions due to fluid flow. 
Moreover, we did observe that using a higher kdc value captured the initial release but greatly 
overestimated the release at day 21. Therefore, the value of kdc was estimated by keeping the best 
possible balance between underestimation of initial and overestimation of final calcium release profile. 
Due to a substantial lack in relevant data on this matter, we restricted ourselves to the use of a fixed 
value for kdc in this study. However, using the value of kdc as an exponentially decreasing function 
rather than a constant value would give a better fit with experimental data. The use of kdc as an 
exponentially decreasing function could take into account the effect of adhesion of precipitated ions 
to the surface as well as the effect of changing pH during the dissolution process. 
 
Additionally, the model was able to predict the spatial-temporal degradation and dissolution of the 
scaffolds (Figure 5 (a-f)). This spatial information represents one of the clear added values of 
computational modelling in the context of designing new biomaterials. No measurement devices exist 
to date that allow this spatial representation of the local calcium concentration - even though these 
local concentrations are what are felt by the cells seeded onto the scaffold. Computational models 
therefore allow to link the insight from in vitro experiments by studying the effect of Ca2+ ions on 
cellular behaviour (Arifin et al. 2006) to the design of optimized biomaterials.  Furthermore, the model 
predicted higher degradation of CaP for Bio-Oss® and Integra-Mozaik™, which was expected due to 
their higher dissolution behaviour (Figure 6). Moreover, the single-parameter sensitivity analyses such 
as the one carried out in this study was able to identify the influence of a few estimated model 
parameters on the final outcome. We found that the solubility (Csol) had a quantitative influence on 
the simulation results (Figure 7(a)). In addition, we observed that the model results were not 
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influenced by the choice in representative 2D image for the investigated scaffolds, except for Integra-
Mozaik™ (Figure 7(b-c)). This was mainly due to heterogeneous structure of Integra-Mozaik™ which 
resulted in variability of surface area (S) of CaP across different image slices. Subsequently, the 
estimated values for kdc and ksc were connected to the material composition properties (such as % 
bovine bone granules, % β-TCP and % HA) of the scaffolds through PLSR to derive kdc* and ksc* values. 
This type of relationships allows estimating dissolution properties of scaffolds based on material 
characteristics without performing in vitro tests. The current relationships, being linear in nature and 
derived from a small sample size, are only indicative and have to be re-evaluated when additional data 
becomes available (additional CaP based scaffold types and n>3 for heterogeneous scaffolds). Yet, the 
approach taken is simple and easily allows for continuous improvement. In addition to allowing to 
estimate the in vitro behaviour of CaP containing scaffolds, the current model can also be used in a 
more proactive way, namely in the design of new CaP containing biomaterials. If a specific calcium 
release window is desired (in order to obtain a specific biological function), the model can be used to 
find the specific geometrical and compositional properties of the scaffold(s) that would lead to the 
desired degradation behaviour. Yet, a limitation of the currently used simple equation for ksc* is it’s 
incapacity to predict a relevant ksc* value for materials containing more than 60% HA. Finally, Figure 8 
shows that a higher amount of β-TCP in the biomaterial resulted in higher dissolution and degradation 
whereas the effect of HA on biomaterial dissolution and degradation was completely the opposite, 
which is in line with common knowledge on CaP based biomaterials (Hong et al. 2014).  
 
6. Conclusion 
This study illustrates the integrative experimental-modelling approach to elucidate mathematically the 
local in vitro dissolution kinetics of CaP-based scaffolds. The model is capable of predicting 
experimentally unmeasurable local in vitro Ca2+ ion concentrations that affect the bone cell chemotaxis 
and proliferation. Even though, we designed and conducted dedicated experiments to determine 
specific model parameter values, the mathematical model still contains some estimated parameter 
values due to the absence of accurate, quantitative data in literature and the complexity of making 
quantitative in vitro measurements. But despite the simplifications and estimations, the model is able 
to recapitulate experimental findings qualitatively. The mathematical modelling of dissolution of CaP-
based biomaterials has significant potential to facilitate understanding and development of complex 
bone tissue engineering constructs (i.e. scaffolds with cells and/or growth factors) in the future. It can 
be used to study numerous design parameters and avoid excessive experimentation, thus saving time 
and resources.  
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Fig. 1 A schematic diagram of combined experimental-modelling approach showing the initial 
estimation of the dissolution constant (kdc) and degradation constant (ksc) from the in vitro dissolution 
tests and then deriving the kdc* and the ksc* by linking the kdc and the ksc respectively, to the structural 
properties measured in the microCT analysis using Partial Least Squares Regression (PLSR). S denotes 
the CaP surface area in the scaffold 
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Fig. 2 Computational domain. Left: Eppendorf tube filled with PBS and the scaffold. (a) Iso-levels of φ 
function (thick line represents the CaP interface Γ where φ = 0). (b) CaP indicator function (𝑰𝛺1) 
computed over the domain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
 
Fig. 3 Typical cross-sectional microCT images of the scaffolds. The CaP phase is clearly visible in light 
grey tones. Arrows indicate the collagen (dark grey) present in Bio-Oss® and Integra-MozaikTM. Scale 
bar: 1mm 
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Fig. 4 Dissolution behaviour of different scaffolds observed experimentally (scatter plot), predicted 
mathematically (solid lines (kdc)) and model corroboration (dashed lines (kdc*)). (a) Bio-Oss®. (b) Integra-
Mozaik™. (c) MBCP™. (d) ReproBone™. In figure (a) and (b) the dotted line coincides with the solid 
lines. Error bars indicate ± standard deviation (n=3)  
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Fig. 5 Dissolution behaviour of Bio-Oss® predicted mathematically. (a) Scaffold shape at day 0, (b) at 
day 10, and (c) at day 21. (d, e, f) Local Ca2+ ion concentration during dissolution at day 0, 10 and 21. 
The circles in images a, b, c highlight degradation of the scaffold 
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Fig. 6 (a) Change in the scaffold surface area (2D) as predicted by the model using kdc and kdc*. D0, day 
0; D21, day 21. (b) Quantitative results of the scaffold CaP volume fraction (%). In figure (b), the data 
has been normalized to the initial total scaffold volume (TSV) leading to fractions. Statistical 
significance: **: p < 0.01, ***: p < 0.001 (n=5 for day 0 and n=1 for day 21). D0, day 0; D21, day 21. 
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Fig. 7 Parameter sensitivity analyses- (a) Influence of the solubility (Csol) on the Ca2+ ions release for 
Bio-Oss®. In figure (a), scatter plot represents the experimental results. Influence of using different 
images with varying initial CaP surface area (S) on the modelling outcome (b) Bio-Oss® and (c) Integra-
Mozaik™. Boxed values indicate the values used in the analyses. In figure (b) and (c) the lines that are 
not visible coincide with the solid line  
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Fig. 8 Investigating the dissolution and degradation behaviour of a biomaterial with multiple 
combinations of β-TCP and HA. (a) Dissolution and (b) degradation behaviour for scaffolds with a 
geometry as that of MBCP but a composition that is a mix of β-TCP and HA.     
  
 
 
